Io Therapeutics io-therapeutics.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180) Neuroscience Startups (947)

Io Therapeutics was founded to develop and commercialize a series of retinoid and rexinoid compounds originally discovered at Allergan. The company's strategy includes expanding the uses of the compounds in its pipeline to address new indications. IRX4204, an RXR agonist originally developed for treatment of cancers, is being developed for neurodegenerative and autoimmune diseases. IRX4310, an RAR antagonist originally developed for dermatologic diseases is being developed for prophylaxis of che...Show all

Io Therapeutics was founded to develop and commercialize a series of retinoid and rexinoid compounds originally discovered at Allergan. The company's strategy includes expanding the uses of the compounds in its pipeline to address new indications. IR...Show all

Company (Alive / Active)

Phone: 650-219-5973

Fax:

1805 E Garry Avenue
Suite 110
Santa Ana, 92705
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Io Therapeutics $0.4M Jan 3, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Io Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.